Clinical trial
A Phase 1, Two Stage, Open Label, Randomized, Single Dose, Comparative Study to Evaluate the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine Product in Healthy Volunteers
NCT04623034 is registered in ClinicalTrials.gov with MSI Methylation Sciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Two Stage, Open Label, Randomized, Single Dose, Comparative Study to Evaluate the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine Product in Healthy Volunteers
- Lead sponsor
- MSI Methylation Sciences, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 17, 2013
- Completion date
- June 8, 2013
- Enrollment
- 34 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.